A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Zhang, Yiqun, Kwok-Shing Ng, Patrick, Kucherlapati, Melanie, Chen, Fengju, Liu, Yuexin, Tsang, Yiu Huen, de Velasco, Guillermo, Jeong, Kang Jin +34 more·2017·Cancer Cell
Cited by (645)
Items 501–600 of 645
- Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samplesNicola Calonaci, Eriseld Krasniqi, Daniel Colic, Stefano Scalera, Giorgia Gandolfi, Salvatore Milite, Konstantin Bräutigam, Andrea Sottoriva, Trevor A. Graham, Leonardo Egidi et al. · 2026 · Nature Genetics
- Congenital infiltrating lipomatosis of the face: Case reportGhita Lahnine, Fatima Saddouki, Zineb Bouanani, Amal Akammar, Nizar El Bouardi, Meriem Haloua, Badreeddine Alami, Youssef A. Lamrani, Mustapha Maâroufi, Meriem Boubbou · 2024 · Radiology Case Reports
- ZDOG: zooming in on dominating genes with mutations in cancer pathwaysRudi Alberts, Jinyu Chen, Louxin Zhang · 2019 · BMC Bioinformatics
- Metabolic Oxidative Stress in Initiation, Progression, and Therapy of CancerSoumen Bera, Amit Verma, Anant Narayan Bhatt, Bilikere Srinivasa Rao Dwarakanath · 2022 · Springer eBooks
- A Roadmap to Immunotherapy: Lesson from the Hallmarks and Signaling Pathways of CancerAfshin Derakhshani, Zeinab Rostami, Hossein Safarpour, Sina Taefehshokr, Neda Jalili Tabrizi, Mahdi Abdoli Shadbad, Omid Kooshkaki, Reza Vaezi Astamal, Antonella Argentiero, Pankaj K. Singh et al. · 2020 · Preprints.org
- Aspirin Regulates Gemcitabine Resistance in Pancreatic Cancer via Inhibiting the PI3K/Akt/mTOR Signaling Pathway and Reversing Epithelial-mesenchymal TransitionHanyu Zhou, Zhiying Yan, Feifei Wei, Muhan Liu, yi liu, Xianming Zhang, Kequn xu, Yingwei Zhu, Yun Xiao · 2021 · Research Square
- Long noncoding RNA UCA1 facilitates cell proliferation and inhibits apoptosis via activating PI3K/Akt pathway in retinoblastomaZhongfang Yuan, Zhaona Li · 2019 · Research Square
- Chemical composition and pharmacological mechanism of Ephedra-Glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19)Qin Qiu, Mingyue Li, Haowen Lin, Shilin Cao, Qu Wang, Xiaoling Li, Zishi Chen, Wenhao Jiang, Yuge Huang, Hui Luo et al. · 2020 · Research Square
- The Eukaryotic mRNA Cap StructureJerry Pelletier, Nahum Sonenberg · 2023 · Encyclopedia of Life Sciences
- Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cellsArtem D. Berezovsky, Oluwademilade Nuga, Indrani Datta, Kimberly Bergman, Thaís S. Sabedot, Katherine Gurdziel, Susan M. Irtenkauf, Laura A. Hasselbach, Yuling Meng, Claudius Mueller et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
- MAGE-A4-Responsive Plasma Cells Promote Non-Small Cell Lung CancerDominique Armstrong, Cheng-Yen Chang, M J Hong, Linda Green, William Hudson, Yichao Shen, Lizhen Song, Sheetal Jammi, Benjamin Casal, Chad J. Creighton et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
- PI3K/mTOR activity sensitizes cancer cells to nucleolar stressMyriam Barz, Alba Corman, Maria Häggblad, Alicia Gonzalez-Serrano, Louise Lidemalm, Matilde Murga, Daniela Hühn, Óscar Fernández-Capetillo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
- Human Kinome In Skeletal Muscle Insulin ResistanceYue Andy Qi · 2017 · Human Biology
- Opportunities and Resistance to Signal-Targeted Therapies in Pancreatic Cancer: What Can we Learn from Proteomic Studies?Célia Cintas, Thibaut Douché, Julie Guillermet‐Guibert · 2018 · Preprints.org
- Quantitative Proteomics to Support Translational Cancer ResearchMelissa A. Hoffman · 2018 · Digital Commons - University of South Florida (University of South Florida)
- The lipid kinase PI3Kα is required for the cohesion and survival of cancer cells disseminated in serous cavitiesBenoît Thibault, A Thole, Céline Basset, Julie Guillermet‐Guibert · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
- Biology of Pancreas and Possible DiseasesGowru Srivani, Begum Dariya, Batoul Farran, Afroz Alam, Ganji Purnachandra Nagaraju · 2019 · Springer eBooks
- Comprehensive and Integrated Genomic Characterization of Human Immunome in CancerYongsheng Li, Todd Triplett, Brandon Burgman, Ming Sun, Daniel James McGrail, Dan Qi, Sachet Ashok Shukla, Erxi Wu, Catherine J. Wu, Anna Capasso et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- Peer Review #3 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.1)"2020 · PeerJ
- Peer Review #3 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.2)"2020 · PeerJ
- Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancerMohammad Askandar Iqbal, Shumaila Siddiqui, Asad Ur Rehman, Farid Ahmad Siddiqui, Prithvi Singh, Bhupender Kumar, Daman Saluja · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- Discovery of novel putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in AML cellsW. Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, Megan McLaughlin, Audrey L Griffith, Annabel K Sangree, Marissa N Feeley, Nazanin Esmaeili Anvar, Eiru Kim, Lori L Bertolet et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- MiR-186 serves as a tumor suppressor in lung adenocarcinoma cells by down-regulation of Shp2 gene and inhibiting PI3K/Akt/mTOR signaling pathwayShaohui Yan, Shufeng Xu, Lei Zheng, Liying Kang, Jun-Li Cao, Ping Wang, Liming Gao · 2020
- Metabolic Oxidative Stress in Initiation, Progression, and Therapy of CancerSoumen Bera, Amit Verma, Anant Narayan Bhatt, Bilikere Srinivasa Rao Dwarakanath · 2021 · Springer eBooks
- EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell FormationNannan Zhu, Qian Hui Wang, Zhidong Wu, Yan Wang, Mu‐Sheng Zeng, Yan Yuan · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
- The HuoXue DiTan Recipe Attenuates Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats by Increasing Autophagy Through the PTEN/PI3K/AKT/mTOR PathwayJiamei Yao, Cui Zhang, YANG Yushu, YANG Haiyan, Dan Zhang, SHI Yongyue, Qiong Chen, Guangwei Zhong · 2021 · Research Square
- M058 Effects of Technical Vocabulary Knowledge on Academic Writing : A Research Article Translation Task(CHALLENGES FOR TERTIARY ENGLISH EDUCATION-JACET's Role in the next Fifty Years)David J. Dalsky · 2011 · JACET全国大会要綱
- Deubiquitinase USP9X loss Sensitizes Cancer Cells to mTOR Inhibitors through p62 DysregulationJuan María Roldán‐Romero, María Santos, Javier Lanillos, Pablo Maroto, Geòrgia Anguera, Bruna Calsina, Ángel M. Martínez‐Montes, María Monteagudo, Sara Mellid, Luis Javier Leandro-Garcia et al. · 2021 · Research Square
- Proteome dynamics under proteotoxic stress and diseaseKevin Klann · 2021
- Systematic Pan-Cancer Analysis Reveals Molecular Characteristics and Clinical Relevance of Serine/Arginine-Rich Splicing Factors in Human CancersCongkuan Song, Jinjin Zhang, Shize Pan, Bo Hao, Ruyuan He, Heng Meng, Donghang Li, Kai Lai, Ning Li, Qing Geng · 2022 · SSRN Electronic Journal
- Peer Review #2 of "Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma (v0.1)"2021 · PeerJ
- Peer Review #1 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.1)"2020 · PeerJ
- Peer Review #1 of "Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma (v0.1)"2021 · PeerJ
- Peer Review #1 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.2)"2020 · PeerJ
- Peer Review #2 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.1)"2020 · PeerJ
- Opportunities and Resistance to Signal-targeted Therapies in Pancreatic Cancer: What Can We Learn from Proteomic Studies?Célia Cintas, Thibaut Douché, Julie Guillermet‐Guibert · 2018 · Preprints.org
- The Lipid Kinase PI3Kα is Required for the Cohesion and Survival of Cancer Cells Disseminated in Serous CavitiesBenoît Thibault, Adrien Thole, Céline Basset, Julie Guillermet‐Guibert · 2021 · SSRN Electronic Journal
- Peer Review #2 of "Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma (v0.2)"2020 · PeerJ
- Faculty Opinions recommendation of Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.David Fruman · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
- KAT8 promotes the resistance of human NSCLC cells to miR-7 intervention via the H4K16/PAX6 axisJing Yang, Xu Zhao, Dongmei Li, Lin Tang, Wen Zheng, Longqinq Chen, Jing Chen, Chao Chen, Ming Qin, Mengmeng Guo et al. · 2022 · Research Square
- Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcomeThiago Vidotto, Camila Morais Melo, William Lautert-Dutra, LP Chaves, RB Reis, Jeremy Andrew Squire · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
- Low FBXL7 Expression Indicates Low Overall Survival in Bladder CancerQier Xia, Xinyue Hu, Jun Li, Yifan Shen, Haibin Wei, Jing Qian, Dahong Zhang · 2022 · Research Square
- Prevalencia de la mutación de PIK3CA en cáncer de mama en la Argentina y su asociación con variables clínico-patológicasPablo Mandó, Rosario Vidal, Ana Alonso, Celia Brosio, Gonzalo Recondo, Gabriel Crimi, Francisco Von Stecher, Valeria Dennighoff, Florencia Perazzo · 2022 · Oncología Clínica
- Data from Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle IrradiationBrian D. Yard, Priyanka Gopal, Kristina Bannik, Gerhard Siemeister, Urs B. Hagemann, Mohamed E. Abazeed · 2023
- Data from Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle IrradiationBrian D. Yard, Priyanka Gopal, Kristina Bannik, Gerhard Siemeister, Urs B. Hagemann, Mohamed E. Abazeed · 2023
- Data from Integrated Genomic Characterization of the Human Immunome in CancerYongsheng Li, Brandon Burgman, Daniel James McGrail, Ming Hua Sun, Dan Qi, Sachet Ashok Shukla, Erxi Wu, Anna Capasso, Shiaw‐Yih Lin, Catherine J. Wu et al. · 2023
- Supplementary Methods from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant CancersKomal L. Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid M. Aljumaily et al. · 2023
- Data from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant CancersKomal L. Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid M. Aljumaily et al. · 2023
- Data from Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant CancersKomal L. Jhaveri, Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk, Manish R. Patel, Vincent Ribrag, Cynthia X. Ma, Raid M. Aljumaily et al. · 2023
- Supplementary Figure 2 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin TreatmentXimena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, Albert J.H. Suurmeijer, Jourik A. Gietema, Marcel A.T.M. van Vugt, Steven de Jong · 2023
- Principles of PI 3K Biology and Its Role in LymphomaRalitsa Radostinova Madsen · 2023 · Wiley eBooks
- Meat enriched-diet and inflammation promote PI3Kα-dependent pancreatic cell plasticity that limit tissue regenerationCoralie Cayron, Dimitra Bozoglou, Amélie V. Villard, Gabriela Reyes‐Castellanos, N Therville, Romain Baer, Silvia Arcucci, Nathalie Naud, Marie Tosolini, Frédéric Pont et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
- Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T-cell receptors for cancer immunotherapy targeting hotspot driver mutationsAishun Jin, Meiying Shen, Siyin Chen, Xiaojian Han, Yanan Hao, Li Luo, Tong Chen, Bozhi Wang, Lin Zou, Junfan Wang et al. · 2023 · Research Square
- Low MYCT1 expression is an independent prognostic predictor and MYCT1 upregulation can induce oral squamous cell carcinoma developmentYuanyuan Xie, Jing He, Wenmin An, Zhenning Li · 2023 · Research Square
- Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian populationSubhajit Malakar, Srilagna Chatterjee, Madhusudhan Das, Dilip Kumar Pal · 2024 · Urologia Journal
- Elucidating the Role of Pro-renin Receptors in Pancreatic Ductal Adenocarcinoma Progression: A Novel Therapeutic Target in Cancer TherapyMohsen Aliakbarian, Gordon A. Ferns, Mahmoud Mohamadzadeh Shabestari, Amir Mahmoud Ahmadzadeh, Aref Abdollahzade, Hoda Rahimi, Rozita Khodashahi, Mohammad‐Hassan Arjmand · 2024 · Current Cancer Drug Targets
- Additional file 3 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 9 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 4 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 2 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 11 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 6 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 10 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 7 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 5 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Xiaoli Ma, Xiaomeng Xie, Bingbing Lu, Kyle Vaughn Laster, Kangdong Liu, Zigang Dong, Dong Joon Kim · 2020 · Figshare
- Additional file 8 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Additional file 1 of The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatmentBisheng Cheng, Lingfeng Li, Yongxin Wu, Tianlong Luo, Chen Tang, Qiong Wang, Qianghua Zhou, Jilin Wu, Yiming Lai, Dingjun Zhu et al. · 2023 · Figshare
- Additional file 5 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Ruiqi Zhang, Du, Changjian, Jiapei Tong, Ni, Yu, Yaqi Zhou, Yongchun Zuo, Mingzhi Liao · 2023 · Figshare
- Study on the effects of rapamycin and the mTORC1/2 dual inhibitor OSI-027 on the metabolism of colon cancer cells based on UPLC-MS/MS metabolomicsKai Fan, Yueyuan Wang, Jiangyujing Bian, Yewen Sun, Jiaqi Dou, Jie Pan, Yunli Yu · 2024 · Investigational New Drugs
- Treatments that Target Cell CommunicationElaine Vickers · 2024
- Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinomaFengchao Yin, Fang Li, Qi Pan, Aili Zhang · 2024 · Open Life Sciences
- Deciphering WNT Signalling Vulnerabilities in Soft Tissue SarcomaMarina Pérez-Capó, Esther Martinez-Font, Elena Prados, Rafael Ramos, Raúl Sánchez Morillas, Maria Rosa Martorell, Oliver Vögler, Regina Alemany, Antònia Obrador‐Hevia · 2025 · Pathobiology
- An exposure–safety analysis to support the dosage of the novel AKT inhibitor capivasertibCarlos Fernández Teruel, Marie Cullberg, Ignacio González-García, Gaia Schiavon, Diansong Zhou · 2025 · Cancer Chemotherapy and Pharmacology
- Integrated functional genomics-identified LYRM4 promotes fumarate accumulation and hepatocellular carcinoma progressionYuan Xu, Yanting Yang, Xinyuan Yu, Linyu Han, Shuqing Liu, Nasha Zhang, Ming Yang · 2025 · Archives of Biochemistry and Biophysics
- An Overview of Analytical Approaches to Cancer ProteogenomicsChad J. Creighton · 2025 · Methods in molecular biology
- Molecular Subtyping and Classification of PIK3CA Mutations in Metastatic Breast CancerAmrit Kaur Kaler, Manish M Jethani, Mandar S. Nadkarni, Yash Tiwarekar, Varsha Balaji, Tanmay Wairkar, Bijal N. Kulkarni, Nevitha Athikari, Shalaka Satpute, Ratika Agarwal et al. · 2025 · Current Tissue Microenvironment Reports
- Kanser Tedavisinde PI3K/AKT/mTOR Yolunun Hedeflenmesi: Yeni Nesil mTOR İnhibitörlerine Güncel Bir DeğerlendirmeErhan Aptullahoğlu · 2025 · Osmaniye Korkut Ata Üniversitesi Fen Bilimleri Enstitüsü Dergisi
- NRF2 Dysregulation and Its Implications in Renal Cell CarcinomaBumjun Jang, Mi‐Kyoung Kwak · 2025 · Drug Targets and Therapeutics
- Molecular Characterization of Seminoma Utilizing the AACR Project GENIE: A Retrospective Observational StudySuchit R. Geereddy, Amber L. Chang, Alma Gallegos, Jonathan T. Lin, Akaash Surendra, Suraj Puvvadi, Beau Hsia, Abubakar Tauseef, Joseph Thirumalareddy, Akshat Sood · 2025 · Cancers
- Molecular approach of renal cell carcinoma using FISH method : a prospective study (23 cases) and state of the artRafik BEN TAYEB, Mohammed Mzyiene, Nizar BOUARDI, Fatimazahra FARHANE, Touria BOUHAFA, Laila Bouguenouch, Nawfel MELLAS, Mustapha MAAROUFI, Moulay Hassan FARIH, hinde el fatemi · 2022 · Research Square
- Additional file 1 of ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathwayChen, Han, 王恒孝, Xiqiao Yu, Zhou, Shuping, Zhang, Yueying, Wang, Zhaopeng, Huang, Shuhong, ZHAOXIA WANG · 2020 · Figshare
- Additional file 12 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 9 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 1 of Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancerDeyu Long, Zhang, Ruiqi, Du, Changjian, Jiapei Tong, Ni, Yu, Zhou, Yaqi, Zuo, Yongchun, Liao, Mingzhi · 2023 · Figshare
- Additional file 4 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 4 of Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitnessMatilde Monti, Benerini Gatta, Luisa, Bugatti, Mattia, Irene Pezzali, Sara Picinoli, Marcello Manfredi, Antonio Lavazza, Virginia Vita Vanella, Veronica De Giorgis, Lucia Zanatta et al. · 2024 · Figshare
- Additional file 5 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 11 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 7 of Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitnessMatilde Monti, Benerini Gatta, Luisa, Bugatti, Mattia, Irene Pezzali, Sara Picinoli, Marcello Manfredi, Antonio Lavazza, Virginia Vita Vanella, Veronica De Giorgis, Lucia Zanatta et al. · 2024 · Figshare
- Additional file 6 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Ma, Xiaoli, Xie, Xiaomeng, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
- Additional file 1 of Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compoundsClaire Blanchard, Alison Gomeiz, Kyle Avery, Gazzah, Emna El, Abduljalil M. Alsubaie, Masoumeh Sikaroodi, Ylenia Chiari, Chelsea Ward, Sanchez, Jonathan, Virginia A. Espina et al. · 2024 · Figshare
- Additional file 2 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 1 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 6 of Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitnessMatilde Monti, Benerini Gatta, Luisa, Bugatti, Mattia, Irene Pezzali, Sara Picinoli, Marcello Manfredi, Antonio Lavazza, Virginia Vita Vanella, Veronica De Giorgis, Lucia Zanatta et al. · 2024 · Figshare
- Additional file 13 of Integrated multi-omics analysis and machine learning developed a prognostic model based on mitochondrial function in a large multicenter cohort for Gastric CancerMa, Yimeng, Jin, Jingjing, Xue, Zixuan, Zhao, Jungang, Cai, Weiyang, Zhang, Wanli · 2024 · Figshare
- Additional file 7 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Ma, Xiaoli, Xiaomeng Xie, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
- Additional file 2 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Ma, Xiaoli, Xiaomeng Xie, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
- Additional file 1 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Ma, Xiaoli, Xie, Xiaomeng, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
- Additional file 3 of 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Ma, Xiaoli, Xiaomeng Xie, Lu, Bingbing, Kyle Vaughn Laster, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon · 2020 · Figshare
- Additional file 1 of Phosphorylation at tyrosine 317 and 508 are crucial for PIK3CA/p110α to promote CRC tumorigenesisWang, Ting, Sun, Longci, Chengkun Chen, Zhang, Yingchao, He, Baoyu, Zhang, Yanhua, Zhenghe Wang, Hanbing Xue, Hao, Yujun · 2023 · Figshare